http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories
-
Aethlon Medical Announces Second Quarter Fiscal Year 2019 Results
-
Aethlon Medical To Release Quarterly Financial Results and Host Conference Call on November 6, 2018
-
Aethlon Medical to Present at the NYC Oncology Conference
-
Aethlon Medical to Present at the 2018 BIO Investor Forum
-
Aethlon Medical Receives National Cancer Institute Award
-
Aethlon Medical Announces First Quarter Fiscal Year 2019 Results
-
Aethlon Medical To Release Financial Results for the First Quarter Fiscal Year 2019 and Host Conference Call on August 8, 2018
-
Aethlon Medical Announces Issuance of Hemopurifier® Patent To Treat Life-Threatening Viruses
-
Aethlon Medical (AEMD) Names Joins Aethlon to Board of Directors
-
Guy Cipriani Joins Aethlon Medical's Board of Directors
-
Aethlon Medical Announces Fiscal 2018 Results
-
Aethlon Medical To Release 2018 Fiscal Year End Financial Results and Host Conference Call on June 8, 2018
-
Study of Blood Test to Detect and Monitor Chronic Traumatic Encephalopathy (CTE) in Former NFL Players Set for Kick-Off in Phoenix
-
Aethlon Medical To Present at the American Society for Microbiology Biothreats Meeting
-
Aethlon Medical Announces Fiscal 2018 Third Quarter Results
-
Aethlon Medical to Release Third Quarter Fiscal Year 2018 Financial Results and Host Conference Call on February 1, 2018
-
Aethlon Medical (AEMD) Reports Validation Completion for European Patent Protecting Methods of Quantifying Exosomes
-
Aethlon Medical Announces Validation Completion for European Patent Protecting Methods of Quantifying Exosomes
-
Aethlon Medical (AEMD) Receives Patent that Broadens Protection for Hemopurifier to Treat Viral Infections
-
Aethlon Medical Announces Allowance of U.S. Patent that Broadens Protection for the Aethlon Hemopurifier® to Treat Viral Infections
-
Aethlon Medical (AEMD) Appoints Sabrina Martucci Johnson to Board
-
Sabrina Martucci Johnson Joins Aethlon Medical's Board of Directors
-
Aethlon Medical (AEMD) Appoints Dr. Charles J. Fisher as Board Chairman
-
Aethlon Medical Names Dr. Charles J. Fisher Chairman of the Board
-
Aethlon Medical (AEMD) Appoints Dr. Charles J. Fisher, Jr. to Board
-
Dr. Charles J. Fisher, Jr. Joins Aethlon Medical's Board of Directors
-
Aethlon Medical Announces Fiscal 2018 Second Quarter Results
-
Aethlon Medical to Release Financial Results for the Second Quarter Fiscal Year 2018 and Host Conference Call on November 2, 2017
-
Aethlon Medical (AEMD) Announces Production Collaboration with iBio, Inc. (IBIO)
-
Aethlon Medical Announces Large-Scale Production Collaboration
-
iBio Announces Manufacturing Collaboration with Aethlon Medical
-
Aethlon Medical to Present at the 2017 BIO Investor Forum
-
Aethlon Medical Announces Compliance With Nasdaq Listing Criteria
-
Aethlon Medical (AEMD) Prices 5.45M Share Offering at $1.10/Sh
-
Aethlon Medical Announces Pricing of $6 Million Public Offering
-
Aethlon Medical Receives National Cancer Institute Contract Award
-
Aethlon Medical (AEMD) Receives FDA Expedited Access Pathway Designation to Accelerate Access to Hemopurifier as Treatment for Life-Threatening Viruses
-
Aethlon Medical Receives Expedited Access Pathway Designation from FDA to Accelerate U.S. Access to the Hemopurifier® as a Treatment for Life-Threatening Viruses
-
Aethlon Medical to Present at the 19th Annual Rodman & Renshaw Global Investment Conference on September 11, 2017
-
Aethlon Medical Announces Fiscal 2018 First Quarter Results
-
Aethlon Medical To Release Financial Results for the First Quarter Fiscal Year 2018 and Host Conference Call on August 10, 2017
-
Aethlon Medical (AEMD) Granted U.S. Patent Protecting Methods of Capturing MHC Antigen Associated Exosomes
-
Aethlon Medical Announces the Grant of a U.S. Patent Protecting Methods of Capturing MHC Antigen Associated Exosomes
-
Aethlon Medical Announces Fiscal 2017 Results
-
Aethlon Medical To Release 2017 Fiscal Year End Financial Results and Host Conference Call on June 28, 2017
-
Aethlon Medical To Present Clinical Study Results at The BIO International Convention
-
Aethlon Medical, Inc., Announces Upcoming Presentation and Webcast at the LD Micro Invitational Conference on June 6, 2017
-
Aethlon to Present at the LD Micro Invitational Conference on June 6, 2017
-
Aethlon Medical Releases Shareholder Update
-
Aethlon Medical Discloses Tech Nation Interview On National Public Radio